Risk factors for difficult‐to‐treat hepatitis C virus genotype 4r in Rwanda and implications for elimination in sub‐Saharan Africa-Reference-Cited by-同舟云学术

Risk factors for difficult‐to‐treat hepatitis C virus genotype 4r in Rwanda and implications for elimination in sub‐Saharan Africa

Published:2021-02-02 Issue:4 Volume:28 Page:682-686
ISSN:1352-0504
Container-title:Journal of Viral Hepatitis
language:en
Short-container-title:J Viral Hepat

Author:

Shumbusho Fabienne¹,Liu Anne F.²^ORCID,Kateera Fredrick¹,Kabahizi Jules³,Nsanzaimana Sabin⁴,Serumondo Janvier⁴,Damascene Makuza Jean⁴⁵^ORCID,Grant Philip M.⁶,Musabeyezu Emmanuel⁷,Muvunyi Claude⁸,Gupta Neil⁹¹⁰^ORCID

Affiliation:

1. Partners In Health/Inshuti Mu Buzima Kigali Rwanda

2. Department of Hepatology, Gastroenterology and Endoscopy Brigham and Women’s Hospital and Harvard Medical School Boston USA

3. Rwanda Military Hospital Kigali Rwanda

4. Rwanda Biomedical Center Kigali Rwanda

5. School of Population and Public Health University of British Columbia Vancouver Canada

6. Department of Infectious Diseases Stanford University Palo Alto USA

7. King Faisal Hospital Kigali Rwanda

8. College of Medicine and Health Sciences University of Rwanda Kigali Rwanda

9. Partners In Health Boston USA

10. Division of Global Health Equity Brigham & Women’s Hospital Boston USA

Publisher

Wiley

Subject

Virology,Infectious Diseases,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jvh.13467

Reference8 articles.

1. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study

2. Treatment of chronic hepatitis C virus infection in Rwanda with ledipasvir–sofosbuvir (SHARED): a single-arm trial

3. Suboptimal SVR rates in African patients with atypical genotype 1 subtypes: Implications for global elimination of hepatitis C

4. Resistance‐associated substitutions in patients with chronic hepatitis C virus genotype 4 infection

5. Frequent Antiviral Treatment Failures in Patients Infected With Hepatitis C Virus Genotype 4, Subtype 4r

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk factors for secondary infection after liver failure and effect of comprehensive nursing intervention;World Journal of Clinical Cases;2024-08-06

2. Safety and efficacy of sofosbuvir–velpatasvir–voxilaprevir for re-treatment of chronic hepatitis C virus infection in patients with previous direct-acting antiviral treatment failure in Rwanda (SHARED-3): a single-arm trial;The Lancet Gastroenterology & Hepatology;2022-06

3. HCV Diagnosis and Sequencing Using Dried Blood Spots from Patients in Kinshasa (DRC): A Tool to Achieve WHO 2030 Targets;Diagnostics;2021-03-15